Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Anti-Snoring Treatment Market: By Devices, By Distribution Channel and Geography
Anti-Snoring Treatment Market: By Devices, By Distribution Channel and Geography
Anti-Snoring Treatment Market size was valued at US$ 4,982.1 million in 2023 , growing at a significant CAGR of 8.9% from 2024-2030. Snoring is a hoarse sound generated when air rushes through relaxed tissues in the throat, causing friction between the tissues and causing vibrations during breathing. Snoring is a frequent occurrence in the population, but it can be a major health issue for some people. Snoring is commonly associated with a sleep problem known as obstructive sleep apnea (OSA) drugs. The mandible advancement devices segment is anticipated to grow at significant CAGR over the forecast years owing to increased demand mandibular advancement device (MAD) are most widely used mouth device for sleep apnea patients. Mandibular advancement device (MAD) resembles a mouth guard used in sports.
Moreover, these devices snap over the upper and lower dental arches and have metal hinges that makes it possible for the lower jaw to move forward. Moreover, rising prevalence of sleep apnea and OSAHS, rise in the geriatric population leading to increasing sleep disorder, which is associated with age, and increasing applications of mandibular advancement devices for treatment of snoring and OSA over CPAP systems.
Study Period
2024-2030Base Year
2023CAGR
8.9%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The rising prevalence of different sleep disorders will drive revenue growth in the global anti-snoring therapy market in the approaching years. According to the American Sleep Association, roughly 50-70 million persons in the United States have a sleep disturbance, with 48 percent reporting snoring. Snoring is believed to affect 40% of women and 57% of men in the United States. Obesity, alcohol intake, sedative prescription usage, chronic nasal congestion, and pregnancy are the key factors leading to the rising incidence of snoring. As a result, increased prevalence and awareness of snoring problems will drive market growth.
North America is likely to hold the highest revenue share of in 2023 and same trend is expected over the forecast period due to the rising obesity rate and the acceptance of unhealthy lifestyles are fuelling the industry's growth. Thus, the availability of a huge untreated population pool, along with increased alcohol and smoking use, which raises the likelihood of developing snoring condition, would boost sales of anti-snoring devices in the region.
Moreover, Presence of large number of players and favourable reimbursement policies are also the factors contributing to the growth of the anti-snoring treatment market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 4,982.1 million |
|
Market CAGR |
8.9% |
|
By Devices |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
The global anti-snoring treatment market size was valued at US$ 4,982.1 million in 2023 and is poised to grow at a CAGR of 8.9% from 2024-2030.
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The market key players are: Sleeping Well, LLC (U.S.), Apnea Sciences Corporation (U.S.), Tomed Dr. Toussaint GmbH (Germany), Sleep Well Enjoy Life, Ltd. (U.K.), MEDiTAS Ltd. (U.K.), GSK plc. (U.K.)
| 1.Executive Summary |
| 2.Global Anti-Snoring Treatment Market Introduction |
| 2.1.Global Anti-Snoring Treatment Market - Taxonomy |
| 2.2.Global Anti-Snoring Treatment Market - Definitions |
| 2.2.1.Devices |
| 2.2.2.Distribution Channel |
| 2.2.3.Region |
| 3.Global Anti-Snoring Treatment Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Anti-Snoring Treatment Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Anti-Snoring Treatment Market By Devices, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Mandible Advancement Devices |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Tongue Stabilizing Devices |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Nasal Devices |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Continuous Positive Airways Pressure Devices |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Chin Straps |
| 5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6.Global Anti-Snoring Treatment Market By Distribution Channel , 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Clinics |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Retail Pharmacies |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. E-commerce |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Anti-Snoring Treatment Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Anti-Snoring Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. Devices Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Mandible Advancement Devices |
| 8.1.2.Tongue Stabilizing Devices |
| 8.1.3.Nasal Devices |
| 8.1.4.Continuous Positive Airways Pressure Devices |
| 8.1.5.Chin Straps |
| 8.1.6.Others |
| 8.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.Clinics |
| 8.2.3.Retail Pharmacies |
| 8.2.4.E-commerce |
| 8.2.5.Others |
| 8.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Anti-Snoring Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Devices Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Mandible Advancement Devices |
| 9.1.2.Tongue Stabilizing Devices |
| 9.1.3.Nasal Devices |
| 9.1.4.Continuous Positive Airways Pressure Devices |
| 9.1.5.Chin Straps |
| 9.1.6.Others |
| 9.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.Clinics |
| 9.2.3.Retail Pharmacies |
| 9.2.4.E-commerce |
| 9.2.5.Others |
| 9.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10.Asia Pacific (APAC) Anti-Snoring Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Devices Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Mandible Advancement Devices |
| 10.1.2.Tongue Stabilizing Devices |
| 10.1.3.Nasal Devices |
| 10.1.4.Continuous Positive Airways Pressure Devices |
| 10.1.5.Chin Straps |
| 10.1.6.Others |
| 10.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.Clinics |
| 10.2.3.Retail Pharmacies |
| 10.2.4.E-commerce |
| 10.2.5.Others |
| 10.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Anti-Snoring Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Devices Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Mandible Advancement Devices |
| 11.1.2.Tongue Stabilizing Devices |
| 11.1.3.Nasal Devices |
| 11.1.4.Continuous Positive Airways Pressure Devices |
| 11.1.5.Chin Straps |
| 11.1.6.Others |
| 11.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.Clinics |
| 11.2.3.Retail Pharmacies |
| 11.2.4.E-commerce |
| 11.2.5.Others |
| 11.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Anti-Snoring Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Devices Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Mandible Advancement Devices |
| 12.1.2.Tongue Stabilizing Devices |
| 12.1.3.Nasal Devices |
| 12.1.4.Continuous Positive Airways Pressure Devices |
| 12.1.5.Chin Straps |
| 12.1.6.Others |
| 12.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.Clinics |
| 12.2.3.Retail Pharmacies |
| 12.2.4.E-commerce |
| 12.2.5.Others |
| 12.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Sleeping Well, LLC |
| 13.2.2.Apnea Sciences Corporation |
| 13.2.3.Tomed Dr. Toussaint GmbH |
| 13.2.4.Sleep Well Enjoy Life, Ltd. |
| 13.2.5.MEDiTAS Ltd. |
| 13.2.6.GSK plc. |
| 13.2.8.Contour Products, Inc. |
| 13.2.9.Theravent, Inc. |
| 13.2.10.MPowRx Health & Wellness Products, Inc. |
| 13.2.11.Innovative Health Technologies |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.